Pricing Log in Create free account
Saturday 17 October 2026 Export IQV’s income statement to Excel — free account

IQVIA Holdings Inc.

IQV Healthcare Diagnostics & Research

IQVIA Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $16.3 billion, up 5.87% from fiscal 2024. In the quarter to June 2026, revenue grew 8.74%, EPS was flat, free cash flow grew 23.3% and total debt rose 3.29%, each against the same quarter a year earlier. Member of the S&P 500; revenue growth for ten consecutive years.

266.90 4.14 −1.53%
Market cap
$44.6B
P/E
32.8×
Fwd P/E
22.3×
Dividend yield
—
F-score
4/9
Altman Z
2.05
Beneish M
−2.59
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

IQVIA Holdings Inc. (IQV) EV/EBITDA

Alert me on EV/EBITDA

As of 16 October 2026, IQVIA Holdings Inc. (IQV) trades at a EV/EBITDA of 17.1×. Over the past ten years it has ranged from 10.4× (June 2016) to 26.0× (June 2021); the current reading is higher than 45% of that period. That is below the Diagnostics & Research industry median of 24.3× and above the Healthcare sector median of 9.2×.

EV/EBITDA, daily

Embed this chart

Annual newest first

Period EV/EBITDA Change
FY2025 15.6× 9.16%
FY2024 14.3× (18.09%)
FY2023 17.5× 3.55%
FY2022 16.9× (30.20%)
FY2021 24.2× 9.62%
FY2020 22.1× 7.45%
FY2019 20.5× 15.20%
FY2018 17.8× (0.50%)
FY2017 17.9× (4.86%)
FY2016 18.8× 50.24%

Quarterly newest first

Period EV/EBITDA Change
Jun 2026 13.5× 7.89%
Mar 2026 12.5× (19.89%)
Dec 2025 15.6× 14.94%
Sep 2025 13.6× 11.82%
42 more quarters

Against its own ten years

Low 10.4× High 26.0×
Ten-year median 17.6×
Current reading's percentile 45

EV/EBITDA against peers

Company EV/EBITDA
NTRA Natera, Inc. compare n/m
DGX Quest Diagnostics Incorporated compare 14.1×
LH Labcorp Holdings Inc. compare 14.5×
IQV IQVIA Holdings Inc. 17.1×
A Agilent Technologies, Inc. compare 26.5×
MTD Mettler-Toledo International, Inc. compare 26.6×
IDXX IDEXX Laboratories, Inc. compare 27.6×
ILMN Illumina, Inc. compare 35.0×
WAT Waters Corporation compare 50.1×
Diagnostics & Research industry median 24.3×
Healthcare sector median 9.2×
Market median 11.0×

What EV/EBITDA is

Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)

The full definition of EV/EBITDA →

More on IQV